RESEARCH TRIANGLE PARK, NC – IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sciences industries, has been named… Read More
Augurex has received UK Conformity Assessed marking for JOINTstat®, authorizing its use in Great Britain for rheumatoid arthritis diagnosis and management. JOINTstat® is a well-established rheumatoid arthritis blood test in… Read More
OTTAWA, ON – The Stem Cell Network (SCN) and Capital BioVentures (CBV) are pleased to announce a new partnership to accelerate the development and commercialization of regenerative medicine innovations in Canada…. Read More
Public funding for Pluvicto™ now available to patients with progressive PSMA-positive metastatic castration-resistant prostate cancer Reimbursement milestone underscores growing recognition of radioligand therapy’s impact in advanced prostate cancer MONTREAL, QC –… Read More
RESEARCH TRIANGLE PARK, NC – IQVIA Laboratories, a leading global drug discovery and development laboratory services organization, announces the launch of Site Lab Navigator, an advanced suite of solutions that… Read More
